Search

VIRIDIAN THERAPEUTICS INC

Avatud

SektorTervishoid

22.13 4.58

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

21.16

Max

22.17

Põhinäitajad

By Trading Economics

Sissetulek

-22M

-127M

Müük

143K

284K

Aktsiakasum

-1.05

Kasumimarginaal

-44,760.211

Töötajad

252

EBITDA

-17M

-119M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+57.72% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. nov 2026

Turustatistika

By TradingEconomics

Turukapital

464M

2.6B

Eelmine avamishind

17.55

Eelmine sulgemishind

22.13

Uudiste sentiment

By Acuity

50%

50%

124 / 339 Pingereas Healthcare

VIRIDIAN THERAPEUTICS INC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. sept 2026, 23:26 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Recent U.S. inflation data adds broader context.

10. sept 2026, 20:13 UTC

Viridian Therapeutics Inc. shares are higher in after-market trading, though they remain below the 20-day moving average and near the lower end of their one-month range.

9. sept 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, declining from an initial drop to a more pronounced decrease amid weak trading.

8. sept 2026, 20:13 UTC

Viridian Therapeutics Inc shares are higher in after-market trading. No specific news was identified to explain the price movement.

3. sept 2026, 19:16 UTC

News

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026. Shares are slightly higher during Thursday's session.

2. sept 2026, 22:06 UTC

News

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026, with a fireside chat accessible via a live webcast. Shares are little changed.

28. aug 2026, 20:02 UTC

Viridian Therapeutics Inc shares are lower today, breaking a trend of higher closes. Broader market pressures from rising U.S. Treasury yields may be influencing this decline.

27. aug 2026, 22:01 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, reflecting notable weakness following a flat start to the session. No specific news was identified.

25. aug 2026, 20:07 UTC

Viridian Therapeutics is gaining amid a broader positive market trend, despite earlier pulling back from a session high. Shares remain above the 20-day moving average.

24. aug 2026, 19:26 UTC

Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.

21. aug 2026, 23:21 UTC

Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.

20. aug 2026, 22:56 UTC

Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.

19. aug 2026, 23:01 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.

17. aug 2026, 20:06 UTC

Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.

14. aug 2026, 19:56 UTC

Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.

13. aug 2026, 19:56 UTC

Correlated Moves

Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.

11. aug 2026, 19:46 UTC

Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.

7. aug 2026, 20:05 UTC

Correlated Moves
News

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6. aug 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5. aug 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4. aug 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

3. aug 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

31. juuli 2026, 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

30. juuli 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

29. juuli 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

28. juuli 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

27. juuli 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

24. juuli 2026, 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

22. juuli 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

21. juuli 2026, 19:51 UTC

Correlated Moves

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

Võrdlus sarnastega

Hinnamuutus

VIRIDIAN THERAPEUTICS INC Prognoos

Hinnasiht

By TipRanks

57.72% tõus

12 kuu keskmine prognoos

Keskmine 33.5 USD  57.72%

Kõrge 41 USD

Madal 22 USD

Põhineb 13 Wall Streeti analüütiku instrumendi VIRIDIAN THERAPEUTICS INC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

13

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

124 / 339 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

help-icon Live chat